[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-european-commission-era4health-joint-transnational-call-iics4all-2027-01":3,"similar-european-commission-era4health-joint-transnational-call-iics4all-2027-01":28},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":9,"deadline_note":8,"duration":8,"trl":8,"relevance":8,"why_relevant":8,"early_career":10,"consortium":11,"first_seen":12,"last_updated":8,"update_note":8,"status":13,"stages":8,"call_frequency":14,"next_call_expected":8,"source_url":7,"created_at":15,"updated_at":16,"last_seen_at":15,"eligible_countries":8,"description":17,"seo_summary":18,"recurring_round":10,"canonical_id":4,"links":19},"european-commission-era4health-joint-transnational-call-iics4all-2027-01","ERA4Health Joint Transnational Call – IICS4all","European Commission","https:\u002F\u002Fera4health.eu\u002Fcalls\u002Fpre_iics4all2027.php",null,"2027-01-14T00:00:00.000Z",false,"Required — multi-national consortium of clinical\u002Fpublic health teams conducting transnational Investigator-Initiated Clinical Studies across multiple countries","2026-11-08T00:00:00.000Z","open","Annual","2026-11-08T09:46:17.234Z","2026-11-08T09:46:51.967Z","Funds multi-national Investigator-Initiated Clinical Studies (IICS) in cardiovascular, autoimmune, metabolic and non-communicable respiratory diseases, including underrepresented populations. Studies should be pragmatic comparative effectiveness and\u002For drug repurposing trials of off-patent drugs demonstrating transnational collaboration across countries.","{\"summary\":\"The ERA4Health IICS4all Joint Transnational Call funds multi-national Investigator-Initiated Clinical Studies in cardiovascular, autoimmune, metabolic and non-communicable respiratory diseases. It targets pragmatic comparative effectiveness trials and drug repurposing studies of off-patent drugs, run by transnational consortia of clinical and public health researchers, with attention to underrepresented populations. The call runs annually under the European Commission's ERA4Health partnership.\",\"meta_description\":\"ERA4Health IICS4all funds transnational clinical studies on cardiovascular, autoimmune, metabolic and respiratory disease, for multi-country teams, from the European Commission.\",\"who_should_apply\":[\"Clinical and public health researchers leading investigator-initiated trials\",\"Multi-national consortia spanning clinical research teams across countries\",\"Research focus on cardiovascular, autoimmune, metabolic or non-communicable respiratory disease\",\"Teams designing pragmatic comparative effectiveness or drug repurposing trials of off-patent drugs\",\"Studies including underrepresented patient populations\"],\"key_dates\":[\"Deadline: 14 January 2027\",\"Call runs annually under ERA4Health\"],\"tips\":[\"Frame the trial design explicitly as pragmatic comparative effectiveness or drug repurposing, the call excludes standard drug-development trials.\",\"Build the consortium around off-patent drug use cases, since novel compound trials fall outside scope.\",\"Show concrete inclusion of underrepresented populations in the study design, not just as a stated aim.\"],\"faq\":[{\"q\":\"What diseases does the ERA4Health IICS4all call fund?\",\"a\":\"Cardiovascular, autoimmune, metabolic and non-communicable respiratory diseases, including studies involving underrepresented populations.\"},{\"q\":\"What type of clinical studies does IICS4all support?\",\"a\":\"Pragmatic comparative effectiveness trials and drug repurposing trials of off-patent drugs led by investigators rather than industry.\"},{\"q\":\"Is a consortium required for ERA4Health IICS4all?\",\"a\":\"Yes, applicants must form a multi-national consortium of clinical and public health teams conducting the study across multiple countries.\"},{\"q\":\"When is the ERA4Health IICS4all deadline?\",\"a\":\"The deadline is 14 January 2027, and the call runs annually.\"}],\"tags\":[\"clinical-trials\",\"cardiovascular-disease\",\"autoimmune-disease\",\"metabolic-disease\",\"respiratory-disease\",\"era4health\",\"consortium-required\",\"drug-repurposing\"]}",{"matchedProgram":8,"resourceSlug":20,"relatedGuides":21,"countryHubs":22,"domainHubs":23,"closingMonth":24,"hasRelated":27,"hasBrowseRelated":27},"horizon-europe",[],[],[],{"slug":25,"label":26},"2027-01","January 2027",true,{"grants":29},[30,35,40,45,49],{"id":31,"name":32,"funder":33,"deadline":9,"budget":34},"hrb-era4health-iics4all-2027","ERA4Health IICS4all 2027","HRB","Up to €650,000 per grant (HRB contribution); up to €1,500,000 total HRB commitment to the call",{"id":36,"name":37,"funder":38,"deadline":9,"budget":39},"research-council-of-norway-iics4all-multi-national-investigator-initiated-cli-2027-01","IICS4all: Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations","Research Council of Norway","€1.3M",{"id":41,"name":42,"funder":43,"deadline":44,"budget":8},"swedish-research-council-project-grant-for-international-collaboration-with-2027-01","Project grant for international collaboration within health research (ERA4HEALTH)","Swedish Research Council","2027-01-21T00:00:00.000Z",{"id":46,"name":47,"funder":43,"deadline":48,"budget":8},"swedish-research-council-project-grant-for-international-collaboration-with-2027-02","Project grant for international collaboration within rare diseases (ERDERA)","2027-02-08T00:00:00.000Z",{"id":50,"name":51,"funder":6,"deadline":44,"budget":8},"regieorgaan-sia-transforming-health-and-care-systems-2027-01","Transforming Health and Care Systems"]